Connatal localized neuroblastoma. The case to delay treatment
- PMID: 8608521
- DOI: 10.1002/(SICI)1097-0142(19960401)77:7<1395::AID-CNCR26>3.0.CO;2-W
Connatal localized neuroblastoma. The case to delay treatment
Abstract
Background: Spontaneous regression is well documented for a subset of widespread neuroblastomas (Stage 4S) and for localized residual tumors after incomplete resection. Possible spontaneous regression of untreated localized neuroblastoma in infants is frequently discussed, but has very rarely been demonstrated clinically.
Methods: We report four patients with localized neuroblastomas detected early; all were tumors of the adrenal gland. One patient was detected antenatally by ultrasound, the other three tumors were detected incidentally by sonography at age of birth, 1 week, and 7 weeks, respectively. In three patients treatment was delayed in order to await a possible spontaneous regression, and in one patient treatment was delayed due to an uncertain diagnosis.
Results: Local tumor growth was observed in three patients, and the tumors were removed 7, 12, and 16 weeks, respectively, after the initial diagnosis of the neuroblastoma. All three patients are free of disease. The fourth patient developed liver metastases 4 weeks after the first suspicion of neuroblastoma. Progressive disease ended in death at the age of 17 months.
Conclusions: None of the four patients showed spontaneous tumor regression. Noninvasive examinations and invasive investigations (in two patients) were unable to predict the tumor's behavior. Based on present knowledge, a general "wait and see" strategy cannot be recommended for early and incidentally detected neuroblastoma patients.
Similar articles
-
Congenital stage 1 neuroblastoma evolved into stage 4s.J Pediatr Hematol Oncol. 2009 Jan;31(1):59-60. doi: 10.1097/MPH.0b013e318180bb84. J Pediatr Hematol Oncol. 2009. PMID: 19125091
-
[4S neuroblastoma with bilateral adrenal tumors].Arch Pediatr. 2004 Dec;11(12):1450-6. doi: 10.1016/j.arcped.2004.09.020. Arch Pediatr. 2004. PMID: 15596333 Review. French.
-
Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.Med Pediatr Oncol. 2001 Jan;36(1):160-2. doi: 10.1002/1096-911X(20010101)36:1<160::AID-MPO1039>3.0.CO;2-G. Med Pediatr Oncol. 2001. PMID: 11464874
-
Maturation of mass-screened localized adrenal neuroblastoma.J Pediatr Surg. 2001 Nov;36(11):1633-6. doi: 10.1053/jpsu.2001.27935. J Pediatr Surg. 2001. PMID: 11685689
-
Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.Am J Pediatr Hematol Oncol. 1992 May;14(2):103-10. Am J Pediatr Hematol Oncol. 1992. PMID: 1530115 Review.
Cited by
-
Neonatal neuroblastoma needs the aggressive treatment?World J Surg. 2012 Sep;36(9):2102-7. doi: 10.1007/s00268-012-1632-y. World J Surg. 2012. PMID: 22547019
-
Heterochronous bilateral adrenal neuroblastoma: stage 4S in early infancy following resection of stage I lesion in the neonatal period.Pediatr Surg Int. 2012 Jan;28(1):59-62. doi: 10.1007/s00383-011-2999-9. Pediatr Surg Int. 2012. PMID: 22009205
-
Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis.Br J Cancer. 2001 Aug 17;85(4):531-7. doi: 10.1054/bjoc.2001.1960. Br J Cancer. 2001. PMID: 11506492 Free PMC article.
-
Suprarenal Masses in Very Young Infants: Is It Safe to Watch and Wait? Report of a SIOPEN Observational Study Results.Cancers (Basel). 2022 Aug 19;14(16):4007. doi: 10.3390/cancers14164007. Cancers (Basel). 2022. PMID: 36011005 Free PMC article.
-
Long-term follow-up of the "wait and see" approach to localized perinatal adrenal neuroblastoma.World J Surg. 2013 Feb;37(2):459-65. doi: 10.1007/s00268-012-1837-0. World J Surg. 2013. PMID: 23135423 Clinical Trial.